Study shows fragile X treatment can incur resistance, suggests ways around it

While the brain acquires resistance to continuous treatment with mGluR5 inhibitor drugs, lasting effects may still arise if dosing occurs intermittently and during a developmental critical period, a new study finds.

Source: ScienceDaily.com